Advanced search
Publication Cover
Expert Opinion on Therapeutic Targets Volume 7, 2003 - Issue 6
Submit an article Journal homepage
38
Views
7
CrossRef citations to date
0
Altmetric
Review

Cancer target discovery using SAGE

Dale Porter Dana-Farber Cancer Institute, 44 Binney Street, D740C, Boston, MA 02115, USA; Department of Medicine, Harvard Medical School, Boston, MA, USA
&
Kornelia Polyak Dana-Farber Cancer Institute, 44 Binney Street, D740C, Boston, MA 02115, USA; Department of Medicine, Harvard Medical School, Boston, MA, USA
Pages 759-769 | Published online: 02 Mar 2005

Bibliography

  • VELCULESCU VE, ZHANG L, VOGELSTEIN B, KINZLER KW: Serial analysis of gene expression. Science (1995) 270(5235):484–487.
  • •First description of SAGE technology.
  • CHEE M, YANG R, HUBBELL E et at Accessing genetic information with high-density DNA arrays. Science (1996) 274(5287):610–614.
  • NACHT M, FERGUSON AT, ZHANG W et al.: Combining serial analysis of gene expression and array technologies to identify genes differentially expressed in breast cancer. Cancer Res. (1999) 59(21):5464–5470.
  • SAWIRIS GP, SHERMAN-BAUST CA, BECKER KG, CHEADLE C, TEICHBERG D, MORIN PJ: Development of a highly specialized cDNA array for the study and diagnosis of epithelial ovarian cancer. Cancer Res. (2002) 62(102923–2928.
  • POLYAK K, RIGGINS GJ: Gene discovery using the serial analysis of gene expression technique: implications for cancer research.Oncol. (2001) 19(11):2948–2958.
  • MADDEN SL, WANG CJ, LANDES G: Serial analysis of gene expression: from gene discovery to target identification. Drug Discov. Today (2000) 5(9):415–425.
  • PATINO WD, MIAN OY, HWANG PM: Serial analysis of gene expression: technical considerations and applications to cardiovascular biology. Circ. Res. (2002) 91(7):565–569.
  • HERMEKING H: Serial analysis of gene expression and cancer. Curt: Opia Oncol (2003) 15(1):44–49.
  • SAHA S, SPARKS AB, RAGO C et al: Using the transcriptome to annotate the genome. Nature Biotechnol (2002) 20(5):508–512.
  • ••Description of LongSAGE.
  • LASH AE, TOLSTOSHEV CM, WAGNER L et al: SAGEmap: a public gene expression resource. Genome Res. (2000) 10(7):1051–1060.
  • STRAUSBERG RL, CAMARGO AA, RIGGINS GJ et al.: An international database and integrated analysis tools for the study of cancer gene expression. Pharmacogenomics J. (2002) 2 (3) : 156–164.
  • JASPER H, BENES V, SCHWAGER C et al.: The genomic response of the Drosophila embryo to JNK signaling. Dev. Cell (2001) 1(4):579–586.
  • JONES SJ, RIDDLE DL, POUZYREV AT et al.: Changes in gene expression associated with developmental arrest and longevity in Caenorhabditis elegans. amine Res. (2001) 11(8):1346–1352.
  • LIANG P: SAGE Genie: a suite with panoramic view of gene expression. Proc. NatL Acad. Sci. USA (2002) 99(18):11547–11548.
  • •Brief introduction to SAGE Genie capabilities.
  • BOON K, OSORIO EC, GREENHUT SF et al.: An anatomy of normal and malignant gene expression. Proc. NatL Acad. Sci. USA (2002) 99(17):11287–11292.
  • LOGING WT, LAL A, SIU IM et al: Identifying potential tumor markers and antigens by database mining and rapid expression screening. amine Res. (2000) 10(9):1393–1402.
  • LEERKES MR, CABALLERO OL, MACKAY A et al.: In silico comparison of the transcriptome derived from purified normal breast cells and breast tumor cell lines reveals candidate upregulated genes in breast tumor cells. Cenomics (2002) 79(2):257–265.
  • MIKSICEK RJ, MYAL Y, WATSON PH, WALKER C, MURPHY LC, LEYGUE E: Identification of a novel breast- and salivary gland-specific, mucin-like gene strongly expressed in normal and tumor human mammary epithelium. Cancer Res. (2002) 62(102736–2740.
  • ST CROIX B, RAGO C, VELCULESCU V et al: Genes expressed in human tumor endothelium. Science (2000) 289(5482):1197–1202.
  • IACOBUZIO-DONAHUE CA, ARGANI P, HEMPEN PM, JONES J, KERN SE: The desmoplastic response to infiltrating breast carcinoma: gene expression at the site of primary invasion and implications for comparisons between tumor types. Cancer Res. (2002) 62(105351–5357.
  • IACOBUZIO-DONAHUE CA, RYU B, HRUBAN RH, KERN SE: Exploring the host desmoplastic response to pancreatic carcinoma: gene expression of stromal and neoplastic cells at the site of primary invasion. Am. J. Pathol (2002) 160(1):91–99.
  • PORTER D, LAHTI-DOMENICI J, KESHAVIAH A et al: Molecular markers in ductal carcinoma in situ of the breast. Mol. Cancer Res. (2003) 1(5):362–375.
  • SPORN MB, SUH N: Chemoprevention: an essential approach to controlling cancer. Nat. Rev. Cancer (2002) 2(7):537–543.
  • SPORN MB, SUH N, MANGELSDORF DJ: Prospects for prevention and treatment of cancer with selective PPARy modulators (SPARMs). Trends Mol. Med. (2001) 7(9):395–400.
  • PIQUEMAL D, COMMES T, MANCHON L et al.: Transcriptome analysis of monocytic leukemia cell differentiation. Cenomics (2002) 80(3):361–371.
  • VAN LIMPT VA, CHAN AJ, VAN SLUIS PG, CARON HN, VAN NOESEL CJ, VERSTEEG R: High 8-like 1 expression in a subset of neuroblastoma cell lines corresponds to a differentiated chromaffin cell type. Int. J. Cancer (2003) 105(1):61–69.
  • PORTER D, LAHTI-DOMENICI J, TORRES-ARZAYUS M, CHIN L, POLYAK K: Expression of high in normal-1 (HIN-1) and uteroglobin related protein-1 (UGRP-1) in adult and developing tissues. Mech. Dev. (2002) 114(1-2):201–204.
  • PORTER DA, KROP IE, NASSER S et al: A SAGE (serial analysis of gene expression) view of breast tumor progression. Cancer Res. (2001) 61(15):5697–5702.
  • ZHANG L, ZHOU W, VELCULESCU VE et al.: Gene expression profiles in normal and cancer cells. Science (1997) 276(5316):1268–1272.
  • WAGHRAY A, SCHOBER M, FEROZE F, YAO F, VIRGIN J, CHEN YQ: Identification of differentially expressed genes by serial analysis of gene expression in human prostate cancer. Cancer Res. (2001) 61(10):4283–4286.
  • ARGANI P, ROSTY C, REITER RE et al: Discovery of new markers of cancer through serial analysis of gene expression: prostate stem cell antigen is overexpressed in pancreatic adenocarcinoma. Cancer Res. (2001) 61(11):4320–4324.
  • RYU B, JONES J, BLADES NJ et al: Relationships and differentially expressed genes among pancreatic cancers examined by large-scale serial analysis of gene expression. Cancer Res. (2002) 62(3):819–826.
  • NACHT M, DRACHEVA T, GAO Y et al: Molecular characteristics of non-small cell lung cancer Proc. Natl. Acad. Li. USA (2001) 98(26):15203–15208.
  • HOUGH C, SHERMAN-BAUST C, ES P et al.: Large-scale serial analysis of gene expression reveals genes differentially expressed in ovarian cancer. Cancer Res. (2000) 60(22):6281–6287.
  • LEE JY, EOM EM, KIM DS, HA-LEE YM, LEE DH: Analysis of gene expression profiles of gastric normal and cancer tissues by SAGE. Cenomics (2003) 82(1):78–85.
  • SAHA S, BARDELLI A, BUCKHAULTS P et al: A phosphatase associated with metastasis of colorectal cancer. Science (2001) 294(5545):1343–1346.
  • ZENG Q, DONG JM, GUO K et al: PRL-3 and PRL-1 promote cell migration, invasion, and metastasis. Cancer Res. (2003) 63(11):2716–2722.
  • RAMASWAMY S, TAMAYO P, RIFKIN R et al.: Multiclass cancer diagnosis using tumor gene expression signatures. Proc. NatL Acad. Sci. USA (2001) 98(26):15149–15154.
  • DENNIS JL, VASS JK, WIT EC, KEITH WN, OIEN KA: Identification from public data of molecular markers of adenocarcinoma characteristic of the site of origin. Cancer Res. (2002) 62(21):5999–6005.
  • BUCKHAULTS P, ZHANG Z, CHEN YC et al: Identifying tumor origin using a gene expression-based classification map. Cancer Res. (2003) 63(14):4144–4149.
  • VOGEL CL, COBLEIGH MA, TRIPATHY D et al.: Efficacy and safety of trastuzumab as a single agent in first-line treatment of HER2-overexpressing metastatic breast cancer. J. Clin. Oncol. (2002) 20(3):719–726.
  • SLAMON DJ, LEYLAND-JONES B, SHAK S et al.: Use of chemotherapy plus a monoclonal antibody against HER2 for metastatic breast cancer that overexpresses HER2. N. Engl J. Med. (2001) 344(10:783–792.
  • DRUKER BJ, TALPAZ M, RESTA DJ et al: Efficacy and safety of a specific inhibitor of the BCR-ABL tyrosine kinase in chronic myeloid leukemia. N Engl. I Med. (2001) 344(14):1031–1037.
  • MENSSEN A, HERMEKING H: Characterization of the c-MYC-regulated transcriptome by SAGE: identification and analysis of c-MYC target genes. Proc. Nati Acad. Sci. USA (2002) 99(9):6274–6279.
  • HE TC, SPARKS AB, RAGO C et al: Identification of c-MYC as a target of the APC pathway. Science (1998) 281(5382):1509–1512.
  • UNTERGASSER G, KOCH HB, MENSSEN A, HERMEKING H: Characterization of epithelial senescence by serial analysis of gene expression: identification of genes potentially involved in prostate cancer. Cancer Res. (2002) 62(20:6255–6262.
  • MADDEN SL, GALELLA EA, ZHU J, BERTELSEN AH, BEAUDRY GA: SAGE transcript profiles for p53-dependent growth regulation. Oncogene (1997) 15(9):1079–1085.
  • POLYAK K, XIA Y, ZWEIER JL, KINZLER KW, VOGELSTEIN B: A model for p53-induced apoptosis. Nature (1997) 389(6648):300–305.
  • YU J, ZHANG L, HWANG PM, RAGO C, KINZLER KW, VOGELSTEIN B: Identification and classification of p53-regulated genes. Proc. Natl. Acad Sci. USA (1999) 96(25):14517–14522.
  • ALDAZ CM, HU Y, DANIEL R, GADDIS S, KITTRELL F, MEDINA D: Serial analysis of gene expression in normal p53 null mammary epithelium. Oncogene (2002) 21(40:6366–6376.
  • •SAGE in a mouse cancer model.
  • SIN N, MENG L, WANG MQ, WEN JJ, BORNMANN WG, CREWS CM: The anti-angiogenic agent fumagillin covalently binds and inhibits the methionine aminopeptidase, MetAP-2. Proc. Nat!. Acad. Sci. USA (1997) 94(12):6099–6103.
  • NANDI S, GUZMAN RC, YANG J: Hormones and mammary carcinogenesis in mice, rats, and humans: a unifying hypothesis. Proc. Natl. Acad. Li. USA (1995) 92(9):3650–3657.
  • FISHER B, DIGNAM J, WOLMARK N et al.: Tamoxifen in treatment of intraductal breast cancer: National Surgical Adjuvant Breast and Bowel Project B-24 randomised controlled trial. Lancet (1999) 353(9169):1993–2000.
  • KATZENELLENBOGEN BS: Estrogen receptors: bioactivities and interactions with cell signaling pathways. Biol. Reprod. (1996) 54(2):287–293.
  • CHARPENTIER A, BEDNAREK A, DANIEL R et al.: Effects of estrogen on global gene expression: identification of novel targets of estrogen action. Cancer Res. (2000) 60:5977–5983.
  • SETH P, KROP I, PORTER D, POLYAK K: Novel estrogen and tamoxifen induced genes identified by SAGE (Serial Analysis of Gene Expression). Oncogene (2002) 21(5):836–843.
  • EPSTEIN AC, GLEADLE JM, MCNEILL LA et al.: C. elegansEGL-9 and mammalian homologs define a family of dioxygenases that regulate HIF by prolyl hydroxylation. Cell (2001) 107(1):43–54.
  • BRUICK RK, MCKNIGHT SL: A conserved family of proly1-4-hydroxylases that modify HIF. Science (2001) 294(5545):1337–1340.
  • SETH P, PORTER D, LAHTI-DOMENICI J, GENG Y, RICHARDSON A, POLYAK K: Cellular and molecular targets of estrogen in normal human breast tissue. Cancer Res. (2002) 62(16):4540–4544.
  • SHERMAN-BAUST CA, WEERARATNA AT, RANGEL LB et al: Remodeling of the extracellular matrix through overexpression of collagen VI contributes to cisplatin resistance in ovarian cancer cells. Cancer Cell (2003) 3(4):377–386.
  • PARKIN DM, BRAY F, FERLAY J, PISANI P: Estimating the world cancer burden: Globocan 2000. Int. J. Cancer (2001) 94(2):153–156.
  • EDWARDS BK, HOWE HL, RIES LA et al.: Annual report to the nation on the status of cancer, 1973-1999, featuring implications of age and aging on US cancer burden. Cancer(2002) 94(10):2766–2792.
  • CHEN J, SUN M, LEES, ZHOU G, ROWLEY JD, WANG SM: Identifying novel transcripts and novel genes in the human genome by using novel SAGE tags. Proc. Nat!. Acad. Li. USA (2002) 99(19):12257–12262.
  • ••Demonstrates the power of SAGE todiscover novel targets.
  • PORTER D, WEREMOWICZ S, KUO WL et al.: A neural survival factor is a candidate oncogene in breast cancer. Proc. Nati Acad. Sci. USA (2003). 100(19):10931–10936.
  • HYMAN E, KAURANIEMI P, HAUTANIEMI S et al.: Impact of DNA amplification on gene expression patterns in breast cancer. Cancer Res. (2002) 62(21):6240–6245.
  • FUJII T, DRACHEVA T, PLAYER A et al.: A preliminary transcriptome map of non-small cell lung cancer. Cancer Res. (2002) 62(12):3340–3346.
  • WANG TL, MAIERHOFER C, SPEICHER MR et al: Digital karyotyping. Proc. Nati Acad. Sci. USA (2002) 99(25):16156–16161.
  • •Description of the digital karyotyping method.
  • DUNN JJ, MCCORKLE SR, PRAISSMAN LA et al.: Genomic signature tags (GSTs): a system for profiling genomic DNA. Genome Res. (2002) 12(10:1756–1765.
  • BAYLIN SB, HERMAN JG: DNA hypermethylation in tumorigenesis: epigenetics joins genetics. Trends Genet. (2000) 16(4):168–174.
  • SHI H, YAN PS, CHEN CM et al.: Expressed CpG island sequence tag microarray for dual screening of DNA hypermethylation and gene silencing in cancer cells. Cancer Res. (2002) 62(11):3214–3220.
  • EVRON E, UMBRICHT CB, KORZ D et al.: Loss of cyclin D2 expression in the majority of breast cancers is associated with promoter hypermethylation. Cancer Res. (2001) 61(6):2782–2787.
  • KROP IE, SGROI D, PORTER DA et al: HIN-1, a putative cytokine highly expressed in normal but not cancerous mammary epithelial cells. Proc. Natl. Acad. Li. USA (2001) 98(17):9796–9801.
  • FERGUSON AT, EVRON E, UMBRICHT CB et al: High frequency of hypermethylation at the 14-3-3 a locus leads to gene silencing in breast cancer. Proc. Nati Acad. Sci. USA (2000) 97(11):6049–6054.
  • EVRON E, DOOLEY WC, UMBRICHT CB et al.: Detection of breast cancer cells in ductal lavage fluid by methylation-specific PCR. Lancet (2001) 357(9265):1335–1336.
  • SCHWERING I, BRAUNINGER A, KLEIN U et al.: Loss of the B-lineage-specific gene expression program in Hodgkin and Reed-Sternberg cells of Hodgkin lymphoma. Blood (2003) 101(4):1505–1512.
  • VAN DEN BERG A, KROESEN BJ, KOOISTRA K et al.: High expression of B-cell receptor inducible gene BIC in all subtypes of Hodgkin lymphoma. Genes Chromosomes Cancer (2003) 37(1):20–28.
  • WECHSLER-REYA RJ: Analysis of gene expression in the normal and malignant cerebellum. Recent Frog. Holm. Res. (2003) 58:227–248.
  • MOLENAAR JJ, VAN SLUIS P, BOON K,VERSTEEG R, CARON HN: Rearrangements and increased expression of cyclin D1 (CCND1) in neuroblastoma. Genes Chromosomes Cancer (2003) 36(3):242–249.
  • GEERTS D, SCHILDERINK N, JORRITSMA G, VERSTEEG R: The role of the MEIS homeobox genes in neuroblastoma. Cancer Lett. (2003) 197(1-2):87–92.
  • FISCHER M, BERTHOLD F: Characterization of the gene expression profile of neuroblastoma cell line IMR-5 using serial analysis of gene expression. Cancer Lett. (2003) 190(1):79–87.
  • GODFRIED MB, VEENSTRA M, V SLUIS P et al.: The N-myc and c-myc downstream pathways include the chromosome 17q genes nm23-H1 and nm23-H2. Oncogene (2002) 21(13):2097–2101.
  • MITAS M, MIKHITARIAN K, HOOVER L et al: Prostate-specific Ets (PSE) factor: a novel marker for detection of metastatic breast cancer in axillary lymph nodes. Br. J. Cancer (2002) 86(6):899–904.
  • ENERBACK C, PORTER DA, SETH P et al: Psoriasin expression in mammary epithelial cells in vitro and in vivo. Cancer Res. (2002) 62(1):43–47.
  • YASUI W, OUE N, ONO S, MITANI Y, ITO R, NAKAYAMA H: Histone acetylation and gastrointestinal carcinogenesis. Ann. NY Acad. Sci. (2003) 983:220–231.
  • OIEN KA, VASS JK, DOWNIE I, FULLARTON G, KEITH WN: Profiling, comparison and validation of gene expression in gastric carcinoma and normal stomach. Oncogene (2003) 22(27):4287–4300.
  • PLAYER A, GILLESPIE J, FUJII T et al.: Identification of TDE2 gene and its expression in non-small cell lung cancer. Int. J. Cancer. (2003) 107(2):238–243.
  • CRNOGORAC-JURCEVIC T, MISSIAGLIA E, BLAVERI E et al: Molecular alterations in pancreatic carcinoma: expression profiling shows that dysregulated expression of S100 genes is highly prevalent. ./. Athol. (2003) 201(1):63–74.
  • CLEGG N, EROGLU B, FERGUSON C, ARNOLD H, MOORMAN A, NELSON PS: Digital expression profiles of the prostate androgen-response program. J. Steroid Biochem. Mol. Biol. (2002) 80(1):13–23.
  • JIANG Y, ZHANG W, KONDO K et al: Gene expression profiling in a renal cell carcinoma cell line: dissecting VHL and hypoxia-dependent pathways. Mol. Cancer Res. (2003) 1(6):453–462.
  • CALD WELL MC, HOUGH C, FURER S, LINEHAN WM, MORIN PJ, GOROSPE M: Serial analysis of gene expression in renal carcinoma cells reveals VHL-dependent sensitivity to TNFa cytotoxicity. Oncogene (2002) 21(6):929–936.
  • CORNELISSEN M, VAN DER KUYL AC,VAN DEN BURG R, ZORGDRAGER F, VAN NOESEL CJ, GOUDSMIT J: Gene expression profile of AIDS-related Kaposfs sarcoma. BMC Cancer (2003) 3(1):7.
  • VAN DER KUYL AC, VAN DEN BURG R, ZORGDRAGER F et al: Primary effect of chemotherapy on the transcription profile of AIDS-related Kaposfs sarcoma. BMC Cancer (2002) 2(1):21.
  • VAN RUISSEN F, JANSEN BJ, DE JONGH GJ, VAN VLIJMEN-WILLEMS IM, SCHALKWIJK J: Differential gene expression in premalignant human epidermis revealed by cluster analysis of serial analysis of gene expression (SAGE) libraries. FASEB J. (2002) 16(2):246–248.
  • VAN RUISSEN F, JANSEN BJ, DE JONGH GJ, ZEEUWEN PL, SCHALKWIJK J: A partial transcriptome of human epidermis. Genomics (2002) 79(5):671–678.

Websites

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Order Reprints Request Corporate Permissions

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

Request Academic Permissions

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.